How Can We Help?
< All Topics


SAMHSA’s Division of Pharmacologic Therapies (DPT), part of SAMHSA’s Center for Substance Abuse Treatment (CSAT), manages the day-to-day oversight activates required to implement federal regulations surrounding the use medications approved by the Food and Drug Administration (FDA) such as methadone and buprenorphine for the treatment of opioid use disorder (OUD) for practitioners and opioid treatment programs (OTPs). Good overview here. (DLU 02/01/2022) 

Table of Contents